Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The collaborative ocular melanoma study.

Arun D Singh1, Tero Kivelä

  • 1Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. singha@ccf.org

Ophthalmology Clinics of North America
|March 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Dose Brachytherapy for Choroidal Melanoma: A Preliminary Report.

Ophthalmology. Retina·2026
Same author

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026
Same author

Ultrasound Biomicroscopy in the Diagnosis and Management of Iris and Ciliary Body Tumors: A Comprehensive Review.

Ocular oncology and pathology·2025
Same author

Early-stage ocular toxocariasis: Progression and histopathologic analysis.

American journal of ophthalmology case reports·2025
Same author

Unifying Diagnosis of Choroidal Indeterminate Melanocytic Tumors-Reply.

JAMA ophthalmology·2025
Same author

Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study.

Ophthalmology science·2025

The Collaborative Ocular Melanoma Study (COMS) reviewed its objectives, design, and findings. This extramural perspective offers insights into this unique randomized trial for ocular melanoma.

Area of Science:

  • Ophthalmology
  • Oncology
  • Clinical Trials

Background:

  • The Collaborative Ocular Melanoma Study (COMS) was a significant clinical trial in ophthalmic oncology.
  • Understanding the objectives and design of COMS is crucial for evaluating its impact on uveal melanoma treatment.

Purpose of the Study:

  • To summarize the main objectives, design features, and key findings of the Collaborative Ocular Melanoma Study (COMS).
  • To provide an independent, extramural perspective on the COMS trial, supplementing existing publications by the study investigators.

Main Methods:

  • This review synthesizes information from the Collaborative Ocular Melanoma Study (COMS).
  • The study focuses on the unique randomized design of COMS, without comparison to non-controlled studies.

Related Experiment Videos

Main Results:

  • The review highlights the major findings and achievements of the COMS trial.
  • Key outcomes and contributions of COMS to the understanding and management of ocular melanoma are presented.

Conclusions:

  • The Collaborative Ocular Melanoma Study (COMS) provided valuable data on ocular melanoma management.
  • This extramural review offers a supplementary perspective on the trial's unique randomized design and significant results.